SCOPODERM

This brand name is authorized in Estonia, Finland, France, Netherlands, New Zealand, Singapore, United Kingdom, South Africa

Active ingredients

The drug SCOPODERM contains one active pharmaceutical ingredient (API):

1 Scopolamine UNII DL48G20X8X - SCOPOLAMINE

Scopolamine is a naturally occurring belladonna alkaloid and has anticholinergic properties. It acts as a competitive antagonist to acetylchloline and other parasympathomimetic agents. Its mechanism of action in the central nervous system in preventing motion sickness has yet to be elucidated. Scopolamine produces classical symptoms of parasympathetic blockade. Read about Scopolamine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SCOPODERM Transdermal patch	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AD01	Scopolamine	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1172483
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 062463, 396250
Country: FR	Base de données publique des médicaments	Identifier(s): 63034382, 63958849
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 377281, 92446
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 18082
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 3625
Country: SG	Health Sciences Authority	Identifier(s): 03114P
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/5.7.2/161